Search clinical trials for: Zoledronic acid i.v. 2 years

Total 3185 results

Assistance Publique Hopitaux De Marseille

Completed

Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid

Hutchinson-Gilford Progeria Syndrome

France
Boston Children's Hospital
Merck Sharp & Dohme LLC; Schering-Plough; Eiger BioPharmaceuticals

Active, not recruiting

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

Progeria

United States
Tianjin Medical University

Unknown

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer (esozao)

Breast Cancer

China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Novartis

Completed

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Breast Cancer

Canada
Stinus Gadegaard Hansen
Odense University Hospital; Research Unit of Health Sciences, Hospital of South... and other collaborators

Recruiting

Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS) (ZABAS)

Bone Loss | Muscle Atrophy | Bariatric Surgery

Denmark
First Affiliated Hospital, Sun Yat-Sen University

Terminated

Bone Loss Treatment From Adjuvant Zoledronate Efficacy (BLAZE)

Breast Neoplasms | Bone Loss

China
University of Louisville
James Graham Brown Cancer Center

Completed

Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis

Breast Cancer

United States
Mohammed Milhem
Rising Tide Foundation

Active, not recruiting

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

Chondrosarcoma

United States
Mario Negri Institute for Pharmacological Research
Associazione Italiana per la Ricerca sul Cancro

Terminated

Pre-operative Zoledronate in Triple Negative Breast Cancer

Breast Cancer

Italy
University of California, San Francisco
National Cancer Institute (NCI)

Terminated

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

Cervical Cancer | Precancerous Condition

United States
Novartis Pharmaceuticals

Completed

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Breast Cancer | Prostate Cancer | Bone Metastasis

Germany
Novartis Pharmaceuticals

Terminated

A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss

Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women

Germany
Central European Cooperative Oncology Group

Terminated

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Prostate Cancer

Montenegro, Slovenia, Serbia, Russian Federation, Austria, Poland, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Lithuania, Romania, Slovakia, South Africa
University of Nebraska

Completed

Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants

Renal Insufficiency

United States
Bezmialem Vakif University

Completed

Efficacy of Four Different Treatment Regimes on Postpartum Hemorrhage

Postpartum Hemorrhage

Turkey
Assistance Publique - Hôpitaux de Paris

Completed

Acute Neurological Complications and Neurodevelopmental Outcome in Children Undergoing Extracorporeal Membrane Oxygenation. (NeurECMO)

Extra Corporeal Membrane Oxygenation

France
Nantes University Hospital

Completed

Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant (HILDEGAZ)

Hematopoietic Stem Cell Transplantation

France
Per Aspenberg

Unknown

Initial Fixation of Bisphosphonate-coated Dental Implants

Pre-integration Failure of Dental Implant

Sweden
Riphah International University

Completed

Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19.

Covid19

Pakistan
University of Edinburgh
NHS Lothian

Recruiting

Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid (TOPaZ)

Osteogenesis Imperfecta

United Kingdom, Ireland
University of Michigan Rogel Cancer Center
Novartis; Aventis Pharmaceuticals

Completed

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Hormone-Refractory Prostate Cancer

United States
University of Virginia
National Cancer Institute (NCI)

Completed

Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density

Breast Cancer | Osteoporosis

United States
Tata Memorial Hospital

Unknown

Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma (ZOL)

Osteosarcoma

India
Mario Negri Institute for Pharmacological Research
Associazione Italiana per la Ricerca sul Cancro

Completed

Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer (YAPPETIZER)

Triple Negative Breast Cancer

Italy
Novartis

Completed

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

Osteoporosis | Postmenopausal

Germany
National Institute of Allergy and Infectious Diseases...

Unknown

Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density

HIV Infections | Osteoporosis | Osteopenia

United States
Azienda Socio Sanitaria Territoriale degli Spedali...

Recruiting

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients (BonEnza)

Prostate Cancer | Bone Metastases

Italy
Amgen
Daiichi Sankyo, Inc.

Completed

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Bone Metastases
Novartis Pharmaceuticals

Completed

Re-treatment of Participants With Paget's Disease Using Zoledronic Acid

Paget's Disease of the Bone

Spain, Canada, New Zealand, Belgium, South Africa, United Kingdom
Martina Hansen's Hospital
University of Oslo; Hormone Laboratory, Aker University Hospital, Oslo, Norway

Recruiting

The Effect of Zoledronic Acid on Patients With Osteoarthritis of the Hip

Osteoarthritis, Hip

Norway
Barbara Ann Karmanos Cancer Institute
United States Department of Defense

Completed

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer

Prostate Cancer

United States
Wuerzburg University Hospital
University of Wuerzburg; Crolll Gmbh

Completed

Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome (ZoMARS)

Bone Marrow Edema

Germany
Medical University Innsbruck

Completed

Bisphosphonate Therapy in MONA Spectrum Disorder

Pain | Fracture | Bone Density
Novartis

Completed

Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)

Osteoporosis

United States, Germany
Children's Hospital Medical Center, Cincinnati

Completed

GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis

Bile Acid Synthesis Defect | Inborn Error of Bile Acid Metabolism | Inborn Error of Bile Acid Conjugation

United States
Institut Paoli-Calmettes

Not yet recruiting

Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas

PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
University Hospital Muenster

Completed

Study in Localized and Disseminated Ewing Sarcoma (EWING2008)

Ewing's Sarcoma

Germany
Novartis

Completed

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis (ROSE)

Osteoporosis

Germany
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Novartis Pharmaceuticals; Eastern Cooperative... and other collaborators

Completed

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Prostate Cancer | Metastatic Cancer

United States, Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

Breast Cancer | Osteoporosis
Technical University of Munich

Completed

Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumors

Germany
Novartis Pharmaceuticals

Completed

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Paget's Disease of Bone

United States, United Kingdom, Canada, New Zealand, Spain, Australia
Massachusetts General Hospital
University of California, San Francisco; San Francisco VA Health Care System

Active, not recruiting

Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

Bone Loss | Bariatric Surgery Candidate

United States
National Taiwan University Hospital

Completed

Denosumab Sequential Therapy (DST)

Osteoporosis

Taiwan
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation

Non-small-cell Lung Cancer

China
Katherine D. Crew

Completed

Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer

Breast Neoplasms | Stage 0 Breast Carcinoma | Stage I Breast Carcinoma | Stage II Breast Carcinoma | Stage III Breast Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Osteoporosis | Ovarian Carcinoma | Hereditary Breast and Ovarian Cancer Syndrome

United States
Novartis Pharmaceuticals

Completed

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Breast Cancer | Bone Loss

Egypt, Taiwan, Hong Kong, Thailand, Argentina, Germany, United Kingdom, Colombia, Belgium, Spain, Philippines, Italy, Brazil, China, Finland, Chile, Guatemala, Netherlands, New Zealand, Switzerland, Portugal, Venezuela, Australia, Czech... and more
Novartis Pharmaceuticals

Completed

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

Breast Cancer

Saudi Arabia, Argentina, Belgium, Spain, Italy, Korea, Republic of, South Africa, France, Netherlands

Search clinical trials for: Zoledronic acid i.v. 2 years

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations